Knowledge is power. Are you facing a new diagnosis or recurrence of Psoriatic Arthritis? The Spine Community Psoriatic Arthritis Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Psoriatic Arthritis. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Psoriatic Arthritis.
You are not alone—The Spine Community is the leading Social Media Application for individuals seeking information, inspiration, and support for back pain and conditions of the spine. The network offers patients and caregivers a thriving community for support and information. Login or register here.
January 10, 2018
TheSpineCommunity Presents: Ask the Expert Series with Dr. David Borenstein TheSpineCommunity Presents: Ask the Expert Series David G. Borenstein, MD will be answering questions in TheSpineCommunity on ankylosing spondylitis (AS) and back pain the week of January 15th. TheSpineCommunity is an online resource center and support community for individuals affected with ankylosing spondylitis and other […]
October 26, 2017
The US Food and Drug Administration recently approved Simponi (golimumab) for the treatment of adult patients with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS), which is administered as a 30-minute infusion. Simponi was originally approved in 2013 for the treatment of moderate-to-severe active rheumatoid arthritis. Simponi® is one of five marketed TNF inhibitors […]
September 25, 2017
Psoriasis is a chronic skin condition caused by an overactive immune system affecting 1-3% of people in the United States. Symptoms include flaking, inflammation, and thick, white, silvery, or red patches of the skin and scalp. Psoriasis can also cause discoloration and pitting of finger and toenails as well as inflammation of the joints and […]
July 31, 2017
Obesity is known to have detrimental effects on the musculoskeletal system because of the added strain on joint structures. Another detrimental effect may be the blunting of a therapeutic response to a therapy. It has previously been reported that decreasing weight in psoriatic arthritis results in an improved responses to treatment with tumor necrosis factor […]
May 17, 2017
Xeljanz (tofacitinib) is currently approved by the U. S. Food and Drug Administration (FDA), for use in the treatment of rheumatoid arthritis. Xeljanz is also being studied in numerous other inflammatory conditions including ankylosing spondylitis, psoriatic arthritis and ulcerative colitis (UC), a form of inflammatory bowel disease. UC is an inflammatory bowel disorder (IBD) as […]
December 20, 2016
By Tom Macek, M.D. The holidays are a time when everyone is encouraged to be of good cheer. But this joyous time of year is a lot less merry for those suffering from chronic bad backs, migraines, arthritis and other pain-inducing ailments. “Any kind of pain can seriously affect your quality of life,” says Dr. […]
September 22, 2016
By David Borenstein MD, Executive Editor, theSpineCommunity.com In January of 2016, the Food and Drug Administration approved Cosentyx® (secukinumab) for the treatment of psoriatic arthritis (PsA) and ankylosing spondylitis. Psoriatic spondylitis, an inflammatory spine disease, is a component of PsA responsive to Cosentyx therapy. The availability of Cosentyx allows another option for PsA patients with spine […]